British Journal of Medicine and Medical Research, ISSN: 2231-0614,Vol.: 3, Issue.: 3 (July-September)
Cardiogenic Shock Complicating Myocardial Infarction: An Updated Review
Adel Shabana1,2, Mohamed Moustafa1, Ayman El-Menyar2,3,4* and Hassan Al-Thani5 1Department of cardiology, Hamad Medical Corporation, Qatar.
2Department of clinical medicine, Weill Cornell Medical School, Qatar.
3Clinical research, Trauma section, Hamad General Hospital, Qatar.
4Cardiology unit, Ahmed Maher Teaching Hospital, Cairo, Egypt.
5Vascular surgery, Hamad general hospital, Doha, Qatar.
Adel Shabana1,2, Mohamed Moustafa1, Ayman El-Menyar2,3,4* and Hassan Al-Thani5
1Department of cardiology, Hamad Medical Corporation, Qatar.
(1) Marianna Mazza, Department of Neurosciences, Catholic University of Sacred Heart, Rome, Italy.
(1) J. P. S. Henriques, University of Amsterdam, Netherlands.
(3) Werdan Karl, University Clinics Halle (Saale), Germany.
Complete Peer review History: http://www.sciencedomain.org/review-history/995
The current review aimed to highlight the update management in patients with ischemic Cardiogenic shock (CS) and its impact on mortality. We reviewed the literature using search engine as MIDLINE, SCOPUS, and EMBASE from January 1982 to October 2012. We used key words: “Cardiogenic Shock”. This traditional narrative review did not expand to explore the mechanical complications or other causes of CS. There were 7193 articles assessed by 3 reviewers. We excluded 4173 irrelevant articles, 1660 non-English articles and 93 case-reports. The current review evaluated 888 articles (880 studies and 8 meta-analyses) that were tackling ischemic CS from different points of view before and after the era of SHOCK trial. Ischemic CS remains the most serious complication of acute MI, being associated with high mortality rate both in the acute and long-term setting, despite the advances in its pathophysiology and management. Further randomized trials and guidelines are needed to save resources and lives in patients sustained ischemic CS.
Myocardial infarction; cardiogenic; shock; management.
DOI : 10.9734/BJMMR/2013/2464Review History Comments